InventisBio (SH:688382) Xin Lang Cai Jing·2025-11-07 06:07Group 1 - Yifang Biotechnology's stock price has dropped 5% on November 7, reaching 25.06 CNY per share, with a trading volume of 264 million CNY and a turnover rate of 2.44%, resulting in a total market capitalization of 14.493 billion CNY [1] - The stock has experienced a continuous decline for four days, with a cumulative drop of 12.94% during this period [1] - Yifang Biotechnology, established on January 11, 2013, and listed on July 25, 2022, focuses on the research, production, and sales of innovative drugs, with its main revenue derived entirely from technology licensing and cooperation [1] Group 2 - Southern Fund has one fund heavily invested in Yifang Biotechnology, specifically the Southern Medical Innovation Stock A (010592), which increased its holdings by 533,700 shares in the third quarter, totaling 3.0189 million shares, representing 4.42% of the fund's net value [2] - The estimated floating loss for the fund today is approximately 3.985 million CNY, with a total floating loss of 11.8342 million CNY during the four-day decline [2] - The Southern Medical Innovation Stock A fund was established on March 2, 2021, with a current size of 1.477 billion CNY, achieving a year-to-date return of 40.7% and a one-year return of 31.46% [2]